Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Diabetes & Metabolic Disorders
Published in: Journal of Diabetes & Metabolic Disorders 2/2020

01-12-2020 | Obesity | Review article

Hostile personality as a risk factor for hyperglycemia and obesity in adult populations: a systematic review

Authors: Christina Vassou, Nathan M. D’Cunha, Nenad Naumovski, Demosthenes B. Panagiotakos

Published in: Journal of Diabetes & Metabolic Disorders | Issue 2/2020

Login to get access

Abstract

Purpose

Several studies have already provided valuable insights into the physiological and genetic causes of hyperglycemia and obesity. Concurrently, personality traits, such as hostility, have been suggested to have an impact on health and illness (i.e., self-reported general health, coronary artery disease, and overall mortality). The present systematic review investigated possible effects of hostility upon metabolic markers, such as high plasma glucose level and obesity among adults. We also attempted to reveal current gaps in knowledge and provide insights for future directions.

Methods

This systematic review was performed following the PRISMA 2009 guidelines to examine current evidence arising from observational studies regarding the potential impact of hostile behavior on hyperglycemia and obesity among adults. Of the initial 139 articles, 13 studies were included.

Results

The evidence supports an association between pre-diabetes and obesity with a hostile temperament in certain populations. The relationship between hostility and hyperglycemia was most common in African American women, in women with a family history of diabetes, in unmarried individuals, in White men, as well as in middle-aged and older people. Regarding obesity, high body mass index (BMI) was associated with a hostile personality, particularly among men. However, the paths by which hostile temperament affects glucose levels and BMI, as well as potential mediating and moderating mechanisms, are not entirely understood.

Conclusions

There is a need for research to enhance the understanding of biological, psychological and social factors related to hostility with a view to prevention and effective intervention.
Literature
1.
2.
Baker CF, Overvad K, Dahm CC. Lean body mass and risk of type 2 diabetes - a Danish cohort study. J Diabetes Metab Disord. 2019;18(2):445–51.PubMedPubMedCentral
3.
Grundy SM. Pre-Diabetes M, Syndrome, Risk C. J Am Coll Cardiol. 2012;59(7):635–43.PubMed
4.
Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279–90.PubMedPubMedCentral
5.
Apenyo T, et al. Abstract P058: hostility attitudes & prevalent or future diabetes among black adults: the Jackson heart study.: Circulation; 2017.
6.
Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118(11):1723–35.
7.
Esmaeilinasab M, Ebrahimi M, Mokarrar MH, Rahmati L, Mahjouri MY, Arzaghi SM. Type II diabetes and personality; a study to explore other psychosomatic aspects of diabetes. J Diabetes Metab Disord. 2016;15(1):54.PubMedPubMedCentral
8.
Jackson CA, Jones NRV, Walker JJ, Fischbacher CM, Colhoun HM, Leese GP, et al. Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland. Diabetologia. 2012;55(11):2938–45.PubMedPubMedCentral
9.
Panagiotakos DB, Pitsavos C, Chrysohoou C, Risvas G, Kontogianni MD, Zampelas A, et al. Epidemiology of overweight and obesity in a greek adult population: the ATTICA study. Obes Res. 2004;12(12):1914–20.
10.
Huang I-C, Lee JL, Ketheeswaran P, Jones CM, Revicki DA, Wu AW. Does personality affect health-related quality of life? A systematic review. Luo N, editor. PLoS ONE. 2017;12(3): e0173806.
11.
Luo J, Manson JE, Weitlauf JC, Shadyab AH, Rapp SR, Garcia L, et al. Personality traits and diabetes incidence among postmenopausal women. Menopause. 2019;26(6):629–36.PubMed
12.
Haukkala A, Konttinen H, Laatikainen T, Kawachi I, Uutela A. Hostility. Anger Control, and Anger Expression as Predictors of Cardiovascular Disease. Psychosom Med. 2010;72(6):556–62.PubMed
13.
Sahoo S, Padhy SK, Padhee B, Singla N, Sarkar S. Role of personality in cardiovascular diseases: An issue that needs to be focused too! Indian Heart J. 2018;70:471–7.
14.
D’ Antono B, Moskowitz DS, Nigam A. The metabolic costs of hostility in healthy adult men and women: Cross-sectional and prospective analyses. J Psychosom Res. 2013;75(3):262–9.
15.
Everson-Rose SA, Clark CJ, Henderson KM, Hostility. Cynical. In Gellman MD, Turner JR, editors, Encyclopedia of Behavioral Medicine. 2013: 993–994.
16.
Abraham S, Shah NG, Roux AD, Hill-Briggs F, Seeman T, Szklo M, et al. Trait anger but not anxiety predicts incident type 2 diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA). Psychoneuroendocrinology. 2015;60:105–13.PubMedPubMedCentral
17.
Hackett RA, Lazzarino AI, Carvalho LA, Hamer M, Steptoe A. Hostility and physiological responses to acute stress in people with type 2 diabetes. Psychosom Med. 2015;77(4):458–66.
18.
Maier KJ, James AE. Hostility and social support explain physical activity beyond negative affect among young men, but not women, in college. Behav Med. 2014;40(1):34–41.
19.
Sutin AR, Ferrucci L, Zonderman AB, Terracciano A. Personality and obesity across the adult life span. J Pers Soc Psychol. 2011;101(3):579–92.PubMedPubMedCentral
20.
Williams ED, Steptoe A, Chambers JC, Kooner JS. Ethnic and gender differences in the relationship between hostility and metabolic and autonomic risk factors for coronary heart disease. Psychosom Med. 2011;73(1):53–8.
21.
Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5.
22.
Group PRISMA-P, Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.
23.
Kawachi I, Sparrow D, Kubzansky LD, Spiro A, Vokonas PS, Weiss ST. Prospective study of a self-report type A scale and risk of coronary heart disease: test of the MMPI-2 type A scale. Circulation. 1998;4(5):405–12. 98(.
24.
Moskowitz DS. Cross-situational generality and the interpersonal circumplex. J Pers Soc Psychol. 1994;66(5):921–33.
25.
Costa PT, McCrae RR. The Revised NEO Personality Inventory (NEO-PI-R). In: Y 1SP United Kingdom, editor. The SAGE Handbook of Personality Theory and Assessment: Volume 2 — Personality Measurement and Testing [Internet]. 1 Oliver’s Yard, 55 City Road. EC1. London: SAGE Publications Ltd; 2008. pp. 179–98. [cited 2020 Jan 6].
26.
Derogatis LR. SCL-90-R: Administration, scoring & procedures manual-II for the (revised) version and other instruments of the psychopathology rating scale series. Clin Psychomet Res. 1992: 1–16.
27.
Nabi H, Kivimaki M, Sabia S, Dugravot A, Lajnef M, Marmot MG, et al. Hostility and trajectories of body mass index over 19 years: the Whitehall II study. Am J Epidemiol. 2008;169(3):347–54.
28.
Shen B-J, Countryman AJ, Spiro A, Niaura R. The prospective contribution of hostility characteristics to high fasting glucose levels: the moderating role of marital status. Diabetes Care. 2008;31(7):1293–8.
29.
Boyle SH, Georgiades A, Brummett BH, Barefoot JC, Siegler IC, Matson WR, et al. Associations between central nervous system serotonin, fasting glucose, and hostility in African American females. Ann Behav Med. 2015;49(1):49–57.
30.
Dimitriadis DG, Mamplekou E, Dimitriadis PG, Komessidou V, Papakonstantinou A, Dimitriadis GD, et al. The association between obesity and hostility: the mediating role of plasma lipids. J Psychiatr Pract. 2016;22(3):166–74. PubMed
31.
Georgiades A, Lane JD, Boyle SH, Brummett BH, Barefoot JC, Kuhn CM, et al. Hostility and fasting glucose in African American women. Psychosom Med. 2009;71(6):642–5.
32.
Tindle HA, Duncan MS, Liu S, Kuller LH, Fugate Woods N, Rapp SR, et al. Optimism, pessimism, cynical hostility, and biomarkers of metabolic function in the Women’s Health Initiative. J Diabetes. 2018;10(6):512–23. PubMed
33.
Knox SS. Hostility and physiological risk in the national heart, lung, and blood institute family heart study. Arch Intern Med. 2004;164(22):2442.
34.
Suarez EC. Sex differences in the relation of depressive symptoms, hostility, and anger expression to indices of glucose metabolism in nondiabetic adults. Health Psychol. 2006;25(4):484–92.PubMed
35.
Fliers E, Kreier F, Voshol PJ, Havekes LM, Sauerwein HP, Kalsbeek A, et al. White adipose tissue: getting nervous: white adipose tissue. J Neuroendocrinol. 2003;15(11):1005–10.
36.
Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas J, Tousoulis D, Toutouza M, et al. Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. Am Heart J. 2004;147(1):106–12.PubMed
37.
Niaura R, Banks SM, Ward KD, Stoney CM, Spiro A, Aldwin CM, et al. Hostility and the metabolic syndrome in older males: the normative aging study. Psychosom Med. 2000;62(1):7–16.
38.
Brydon L, Strike PC, Bhattacharyya MR, Whitehead DL, McEwan J, Zachary I, et al. Hostility and physiological responses to laboratory stress in acute coronary syndrome patients. J Psychosom Res. 2010;68(2):109–16.PubMedPubMedCentral
39.
Vella EJ, Friedman BH. Hostility and anger in: Cardiovascular reactivity and recovery to mental arithmetic stress. Int J Psychophysiol. 2009;72(3):253–9.PubMedPubMedCentral
40.
Surwit RS, Williams RB, Siegler IC, Lane JD, Helms M, Applegate KL, et al. Hostility, race, and glucose metabolism in nondiabetic individuals. Diabetes Care. 2002;25(5):835–9.
41.
Pradhan AD. C-Reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327. PubMed
42.
Calhoun PS, Bosworth HB, Siegler IC, Bastian LA. The relationship between hostility and behavioral risk factors for poor health in women veterans. Prev Med. 2001;33(6):552–7.
43.
Barefoot JC, Dodge KA, Peterson BL, Dahlstrom WG, Williams RB. The Cook-Medley hostility scale: item content and ability to predict survival. Psychosom Med. 1989;51(1):46–57.PubMed
44.
Joseph JJ, Golden SH. Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus: Role of cortisol in stress, depression, and diabetes. Ann NY Acad Sci. 2017;1391(1):20–34.PubMed
45.
Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365(9467):1333–46. PubMed
46.
Bunde J, Suls J. A quantitative analysis of the relationship between the Cook-Medley Hostility Scale and traditional coronary artery disease risk factors. Health Psychol. 2006;25(4):493–500.PubMed
47.
JACC Study Group. Ikeda A, Iso H, Toyoshima H, Fujino Y, Mizoue T, et al. Marital status and mortality among Japanese men and women: the Japan Collaborative Cohort Study. BMC Public Health. 2007;7(1):73.PubMedCentral
48.
Kamarck TW, Everson SA, Kaplan GA, Manuck SB, Jennings JR, Salonen R, et al. Exaggerated blood pressure responses during mental stress are associated with enhanced carotid atherosclerosis in middle-aged Finnish men: findings from the Kuopio Ischemic Heart Disease Study. Circulation. 1997;96(11):3842–8.PubMed
49.
Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C. The epidemiology of Type 2 diabetes mellitus in Greek adults: the ATTICA study. Diabet Med. 2005;22(11):1581–8.PubMed
50.
Räikkönen K, Matthews KA, Salomon K. Hostility predicts metabolic syndrome risk factors in children and adolescents. Health Psychol. 2003;22(3):279–86.PubMed
51.
Barefoot JC, Peterson BL, Dahlstrom WG, Siegler IC, Anderson NB, Williams RB. Hostility patterns and health implications: correlates of Cook–Medley Hostility Scale scores in a national survey. Health Psychol. 1991;10:18–24.PubMed
52.
Miller TQ, Smith TW, Turner CW, Guijarro ML, Hallet AJ. A meta-analytic review of research on hostility and physical health. Psychol Bull. 1996;119:322–48.PubMed
53.
Nabi H, Kivimaki M, Zins M, Elovainio M, Consoli SM, Cordier S, et al. Does personality predict mortality? Results from the GAZEL French prospective cohort study. Int J Epidemiol. 2008;37(2):386–96.PubMedPubMedCentral
54.
Tindle HA, Chang Y-F, Kuller LH, Manson JE, Robinson JG, Rosal MC, et al. Optimism, cynical hostility, and incident coronary heart disease and mortality in the women’s health initiative. Circulation. 2009;120(8):656–62.
55.
Everson SA, Kauhanen J, Kaplan GA, Goldberg DE, Julkunen J, Tuomilehto J, et al. Hostility and increased risk of mortality and acute myocardial infarction: the mediating role of behavioral risk factors. Am J Epidemiol. 1997;146(2):142–52.
56.
Blaine BE, Rodman J, Newman JM. Weight loss treatment and psychological well-being: a review and meta-analysis. J Health Psychol. 2007;12(1):66–82.
57.
Walker LLM, Gately PJ, Bewick BM, Hill AJ. Children’s weight-loss camps: psychological benefit or jeopardy? Int J Obes. 2003;27(6):748–54.
58.
Panotopoulos G, Raison J, Ruiz JC, Guy-Grand B, Basdevant A. Weight gain at the time of menopause. Hum Reprod. 1997;12(suppl 1):126–33. PubMed
59.
van den Bree MBM, Przybeck TR, Robert Cloninger C. Diet and personality: associations in a population-based sample. Appetite. 2006;46(2):177–88.
60.
Moher D, Pham B, Lawson M, Klassen T. The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Health Technol Assess. 2003 [cited 2020 Mar 4];7(41).
61.
Morrison A, Polisena J, Husereau D, Moulton K, Clark M, Fiander M, et al. The effect of english-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care. 2012;28(2):138–44.
62.
Egger M, Zellweger-Zähner T, Schneider M, Junker C, Lengeler C, Antes G. Language bias in randomised controlled trials published in English and German. Lancet. 1997;350(9074):326–9. PubMed
63.
Klassen TP, Pham B, Lawson ML, Moher D. For randomized controlled trials, the quality of reports of complementary and alternative medicine was as good as reports of conventional medicine. J Clin Epidemiol. 2005;58(8):763–8.PubMed
64.
Jüni P, Holenstein F, Sterne J, Bartlett C, Egger M. Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol. 2002;31(1):115–23.PubMed
65.
Moher D, Fortin P, Jadad AR, Jüni P, Klassen T, Le Lorier J, et al. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet. 1996;347(8998):363–6. PubMed
66.
Zhang D, Freemantle N, Cheng KK. Are randomized trials conducted in China or India biased? A comparative empirical analysis. J Clin Epidemiol. 2011;64(1):90–5.PubMed
67.
Zinszer KM, Mulhern JL, Kareem AA. The implementation of the chronic care model with respect to dealing with the biopsychosocial aspects of the chronic disease of diabetes. Adv Skin Wound Care. 2011;24(10):475–84. PubMed
68.
Segal L, Leach MJ, May E, Turnbull C. Regional Primary Care Team to Deliver Best-Practice Diabetes Care. A needs-driven health workforce model reflecting a biopsychosocial construct of health. Diabetes Care. 2013;36(7):1898–907.PubMedPubMedCentral
69.
University of Southern California. Bera K, Bota R. University of California, Hsu R, University of Stanford. Biopsychosocial Approach to the Treatment of Obesity: A Retrospective Review. OWL. 2016;1(1):1–4.
70.
Khalid A, Naz M. A clinical study on the effectiveness of biopsychosocial-spiritual treatment approach for diabetic patient. J Pak Med Assoc. 2019;(0):1.
Metadata
Title
Hostile personality as a risk factor for hyperglycemia and obesity in adult populations: a systematic review
Authors
Christina Vassou
Nathan M. D’Cunha
Nenad Naumovski
Demosthenes B. Panagiotakos
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 2/2020
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00551-y

Other articles of this Issue 2/2020

Journal of Diabetes & Metabolic Disorders 2/2020 Go to the issue

Research article

Application of protection motivation theory to diabetic foot care Behaviours in Egypt

Research article

Prevalence of peripheral neuropathy and associated pain in patients with diabetes mellitus: Evidence from a cross-sectional study

Research article

Insulin injection practices among youngsters with diabetes in Tikur Anbesa Specialized Hospital, Ethiopia

Letter to the Editor

Letter to the editor - Transcranial direct current stimulation improves quality of life and physical fitness in diabetic polyneuropathy: a pilot double blind randomized controlled trial”

Research article

Association of microbiota-derived propionic acid and Alzheimer’s disease; bioinformatics analysis

Research article

Glucose, lipid and oxidative stress lowering activity of the aqueous extract from leafy stems of Cissus polyantha Gilg & Brandt in dexamethasone-induced hyperglycemia in rats
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits